257 related articles for article (PubMed ID: 9067927)
1. Correspondence between stone composition and urine supersaturation in nephrolithiasis.
Parks JH; Coward M; Coe FL
Kidney Int; 1997 Mar; 51(3):894-900. PubMed ID: 9067927
[TBL] [Abstract][Full Text] [Related]
2. Dependence of upper limit of metastability on supersaturation in nephrolithiasis.
Asplin JR; Parks JH; Coe FL
Kidney Int; 1997 Dec; 52(6):1602-8. PubMed ID: 9407506
[TBL] [Abstract][Full Text] [Related]
3. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of factors involved in calcium stone formation.
Abraham PA; Smith CL
Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
[TBL] [Abstract][Full Text] [Related]
5. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
[TBL] [Abstract][Full Text] [Related]
6. Supersaturation and stone composition in a network of dispersed treatment sites.
Asplin J; Parks J; Lingeman J; Kahnoski R; Mardis H; Lacey S; Goldfarb D; Grasso M; Coe F
J Urol; 1998 Jun; 159(6):1821-5. PubMed ID: 9598467
[TBL] [Abstract][Full Text] [Related]
7. Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule.
Tiselius HG
Urol Res; 1997; 25(2):153-9. PubMed ID: 9144885
[TBL] [Abstract][Full Text] [Related]
8. Divergence between stone composition and urine supersaturation: clinical and laboratory implications.
Lingeman J; Kahnoski R; Mardis H; Goldfarb DS; Grasso M; Lacy S; Scheinman SJ; Asplin JR; Parks JH; Coe FL
J Urol; 1999 Apr; 161(4):1077-81. PubMed ID: 10081841
[TBL] [Abstract][Full Text] [Related]
9. [Correlations between crystalluria and composition of calculi].
Kaid-Omar Z; Daudon M; Attar A; Semmoud A; Lacour B; Addou A
Prog Urol; 1999 Sep; 9(4):633-41. PubMed ID: 10555214
[TBL] [Abstract][Full Text] [Related]
10. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time.
Parks JH; Coe FL; Evan AP; Worcester EM
Nephrol Dial Transplant; 2009 Jan; 24(1):130-6. PubMed ID: 18662977
[TBL] [Abstract][Full Text] [Related]
11. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
[TBL] [Abstract][Full Text] [Related]
12. Essential arterial hypertension and stone disease.
Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Supersaturation Outputs from Different Programs and Their Application in Testing Correspondence with Kidney Stone Composition.
Rodriguez A; Cunha TDS; Rodgers AL; Gambaro G; Ferraro PM
J Endourol; 2021 May; 35(5):687-694. PubMed ID: 33050741
[No Abstract] [Full Text] [Related]
14. Relative Supersaturation of 24-Hour Urine and Likelihood of Kidney Stones.
Prochaska M; Taylor E; Ferraro PM; Curhan G
J Urol; 2018 May; 199(5):1262-1266. PubMed ID: 29132983
[TBL] [Abstract][Full Text] [Related]
15. Measurements of urinary state of saturation with respect to calcium oxalate and brushite (CaHPO4.2H2O) in renal stone formers.
Sriboonlue P; Prasongwattana V; Tungsanga K; Sitprija V
J Med Assoc Thai; 1990 Dec; 73(12):684-9. PubMed ID: 2086716
[TBL] [Abstract][Full Text] [Related]
16. Reduced crystallization inhibition by urine from women with nephrolithiasis.
Asplin JR; Parks JH; Nakagawa Y; Coe FL
Kidney Int; 2002 May; 61(5):1821-9. PubMed ID: 11967033
[TBL] [Abstract][Full Text] [Related]
17. Reduced crystallization inhibition by urine from men with nephrolithiasis.
Asplin JR; Parks JH; Chen MS; Lieske JC; Toback FG; Pillay SN; Nakagawa Y; Coe FL
Kidney Int; 1999 Oct; 56(4):1505-16. PubMed ID: 10504502
[TBL] [Abstract][Full Text] [Related]
18. Calcium stone disease: a multiform reality.
Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
[TBL] [Abstract][Full Text] [Related]
19. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
[TBL] [Abstract][Full Text] [Related]
20. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Asplin JR
J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
